Patents by Inventor Arati A. Deshpande

Arati A. Deshpande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nasal calcitonin formulations containing chlorobutanol
    Patent number: 8486891
    Abstract: An aqueous solution of calcitonin suitable for intranasal administration comprised of calcitonin, chlorobutanol at a concentration of less than 0.4% weight/weight, and water and having a pH of less than 4 with the proviso that benzalkonium chloride is not present in the solution. The aqueous solution of calcitonin can be used to treat osteoporosis, Paget's bone disease and hypercalcemia.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: July 16, 2013
    Assignee: Par Pharmaceutical, Inc.
    Inventors: Steven C. Quay, Jorge C. de Meireles, Arati Deshpande, Zenaida O. Go, Anthony P. Sileno
  • NASAL CALCITONIN FORMULATIONS CONTAINING CHLOROBUTANOL
    Publication number: 20120142592
    Abstract: An aqueous solution of calcitonin suitable for intranasal administration comprised of calcitonin, chlorobutanol at a concentration of less than 0.4% weight/weight, and water and having a pH of less than 4 with the proviso that benzalkonium chloride is not present in the solution. The aqueous solution of calcitonin can be used to treat osteoporosis, Paget's bone disease and hypercalcemia.
    Type: Application
    Filed: February 10, 2012
    Publication date: June 7, 2012
    Inventors: Steven C. Quay, Jorge C. de Meireles, Arati A. Deshpande, Zenaida O. Go, Anthony P. Sileno
  • Nasal calcitonin formulations containing chlorobutanol
    Patent number: 8138149
    Abstract: An aqueous solution of calcitonin suitable for intranasal administration comprised of calcitonin, chlorobutanol at a concentration of less than 0.4% weight/weight, and water and having a pH of less than 4 with the proviso that benzalkonium chloride is not present in the solution. The aqueous solution of calcitonin can be used to treat osteoporosis, Paget's bone disease and hypercalcemia.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: March 20, 2012
    Assignee: Par Pharmaceutical, Inc.
    Inventors: Steven C. Quay, Jorge C. de Meireles, Arati Deshpande, Zenaida O. Go, Anthony P. Sileno
  • NASAL CALCITONIN FORMULATIONS CONTAINING CHLOROBUTANOL
    Publication number: 20110009321
    Abstract: An aqueous solution of calcitonin suitable for intranasal administration comprised of calcitonin, chlorobutanol at a concentration of less than 0.4% weight/weight, and water and having a pH of less than 4 with the proviso that benzalkonium chloride is not present in the solution. The aqueous solution of calcitonin can be used to treat osteoporosis, Paget's bone disease and hypercalcemia.
    Type: Application
    Filed: September 9, 2010
    Publication date: January 13, 2011
    Inventors: Steven C. Quay, Jorge C. de Meireles, Arati A. Deshpande, Zenaida O. Go, Anthony P. Sileno
  • Nasal calcitonin formulations containing chlorobutanol
    Patent number: 7812120
    Abstract: Compositions suitable for intranasal administration containing calcitonin, chlorobutanol, a pH of about 3.5, and sodium chloride, and an intranasal spray and a pharmaceutical delivery device thereof.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: October 12, 2010
    Assignee: Par Pharmaceutical, Inc.
    Inventors: Steven C. Quay, Jorge C. de Meireles, Arati A. Deshpande, Zenaida O. Go, Anthony P. Sileno
  • Nasal calcitonin formulations containing chlorobutanol
    Publication number: 20040224890
    Abstract: An aqueous solution of calcitonin suitable for intranasal administration comprised of calcitonin, chlorobutanol at a concentration of less than 0.4% weight/weight, and water and having a pH of less than 4 with the proviso that benzalkonium chloride is not present in the solution. The aqueous solution of calcitonin can be used to treat osteoporosis, Paget's bone disease and hypercalcemia.
    Type: Application
    Filed: March 22, 2004
    Publication date: November 11, 2004
    Applicant: Nastech Pharmaceutical Company Inc.
    Inventors: Steven C. Quay, Jorge C. de Meireles, Arati A. Deshpande, Zenaida O. Go, Anthony P. Sileno